C. Bryce
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 7
- Cancer, Hypoxia, and Metabolism 1
- Oncology 6
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 2
- Co-authors
- Ivo A. Olivotto (5 shared papers)Stephen Chia (3 shared papers)Caroline Speers (2 shared papers)Anthony W. Tolcher (4 shared papers)Donna Mates (3 shared papers)Jeremy S. H. Jackson (3 shared papers)Malcolm Hayes (1 shared paper)Joseph Ragaz (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer (2 papers)Annals of Oncology (2 papers)The Lancet (1 paper)Clinical Oncology (1 paper)
- Partner nations
- CanadaHungarySwitzerland
In The Last Decade
C. Bryce
15 papers receiving 695 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 369
- Oncology 282
- Pulmonary and Respiratory Medicine 131
- Pathology and Forensic Medicine 68
- Genetics 84
Countries citing papers authored by C. Bryce
This map shows the geographic impact of C. Bryce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bryce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bryce more than expected).
Fields of papers citing papers by C. Bryce
This network shows the impact of papers produced by C. Bryce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bryce. The network helps show where C. Bryce may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Bryce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer. | 2001 | 167 |
| 2 | 2004 | 119 | |
| 3 | 1998 | 111 | |
| 4 | 2000 | 96 | |
| 5 | 1999 | 81 | |
| 6 | 2006 | 80 | |
| 7 | 1996 | 55 | |
| 8 | 1998 | 9 | |
| 9 | 2005 | 7 | |
| 10 | 1998 | 3 | |
| 11 | 2009 | 3 | |
| 12 | 1998 | 2 | |
| 13 | 2002 | 1 | |
| 14 | 2002 | 1 | |
| 15 | 2009 | 1 |
About C. Bryce
C. Bryce is a scholar working on Cancer Research, Oncology, Surgery, Molecular Biology and Pharmacology, having authored 15 papers that have together received 736 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (2 papers), Metabolism, Diabetes, and Cancer (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Urinary and Genital Oncology Studies (1 paper), Renal cell carcinoma treatment (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Cancer Research (369 citations), Oncology (282 citations), Pulmonary and Respiratory Medicine (131 citations), Pathology and Forensic Medicine (68 citations) and Genetics (84 citations). C. Bryce has collaborated with scholars based in Canada, Hungary and Switzerland. Frequent co-authors include Ivo A. Olivotto, Stephen Chia, Caroline Speers, Anthony W. Tolcher, Donna Mates, Jeremy S. H. Jackson, Malcolm Hayes, Joseph Ragaz, Nicholas Murray and Martin Gleave. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, The Lancet and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.